Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Nikolaidou, Eirini; Kaufmann, Justus; Wollschlaeger, Daniel et al.
Influence of FDG-PET/CT on the Identification of regional Lymph Node Metastases and Delineation of the Primary Tumor in Patients with Esophageal CancerSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 199. 2023 S. S72-S72
Battista, Marco Johannes; Anic, Katharina; Schmidt, Mona et al.
Influence of Frailty, preoperative Anemia and perioperative Transfusion Management on Survival of elderly Patients with gynecologic MalignanciesZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE. Bd. 56. 2023 S. S4-S4
Keller, Magdalena; Rohlf, Katharina; Glotzbach, Annika et al.
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growthJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. Bd. 42. H. 1. 2023
Zahnreich, Sebastian; El Guerzify, Soumia; Disque-Kaiser, Ursula et al.
Inhibition of the ATR axis enhances the activity of the cGAS-STING/type-I-IFN pathway in head and neck cancer after irradiationSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 199. 2023 S. S39-S40
Doehner, Hartmut; Weber, Daniela; Krzykalla, Julia et al.
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with <i>NPM1</i>-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trialLANCET HAEMATOLOGY. Bd. 10. H. 7. 2023
Van Der Perk, M. E. Madeleine; Broer, Linda; Yasui, Yutaka et al.
INTER-INDIVIDUAL VARIATION IN GONADOTOXICITY IN FEMALE CHILDHOOD CANCER SURVIVORS - A GENOME-WIDE ASSOCIATION STUDY: RESULTS FROM THE PANCARELIFE STUDYPEDIATRIC BLOOD & CANCER. Bd. 70. 2023 S. S130-S131
Bartsch, Rupert; Harbeck, Nadia; Wrobel, Denise et al.
Interim analysis (n=200) from ELEANOR: a multinational, prospective, non-interventional study among patients with HER2+and HR+ early breast cancer treated with extended adjuvant neratinib in the clinical routineCANCER RESEARCH. Bd. 83. H. 5. 2023
Bartsch, R.; Harbeck, N.; Wrobel, D. et al.
Interim analysis (n=200) of ELEANOR: a multi-national, prospective, non-interventional study among patients with HER2+and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib in the clinical routineONCOLOGY RESEARCH AND TREATMENT. Bd. 46. 2023 S. 170-171
Bartsch, R.; Harbeck, N.; Wrobel, D. et al.
Interim analysis of ELEANOR (n=200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+and HR+ early breast cancer (eBC) treated with extended adjuvant neratinibBREAST. Bd. 68. 2023 S. S20-S21
Singer, Susanne; Al-Ibraheem, Akram; Pinto, Monica et al.
International Phase IV Field Study for the Reliability and Validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34THYROID. 2023